0001104659-24-023650.txt : 20240214
0001104659-24-023650.hdr.sgml : 20240214
20240214161301
ACCESSION NUMBER: 0001104659-24-023650
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240212
FILED AS OF DATE: 20240214
DATE AS OF CHANGE: 20240214
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Rowe Michael M
CENTRAL INDEX KEY: 0001744774
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38365
FILM NUMBER: 24638263
MAIL ADDRESS:
STREET 1: C/O EYENOVIA, INC.
STREET 2: 501 FIFTH AVENUE, SUITE 1404
CITY: NEW YORK
STATE: NY
ZIP: 10017
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: EYENOVIA, INC.
CENTRAL INDEX KEY: 0001682639
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 471178401
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 295 MADISON AVENUE,
STREET 2: SUITE 2400
CITY: NEW YORK
STATE: NY
ZIP: 10017
BUSINESS PHONE: 813-766-9539
MAIL ADDRESS:
STREET 1: 295 MADISON AVENUE,
STREET 2: SUITE 2400
CITY: NEW YORK
STATE: NY
ZIP: 10017
4
1
tm245989-2_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2024-02-12
0
0001682639
EYENOVIA, INC.
EYEN
0001744774
Rowe Michael M
C/O EYENOVIA, INC.
295 MADISON AVENUE, SUITE 2400
NEW YORK
NY
10017
1
1
0
0
Chief Executive Officer
0
Stock Option (right to buy)
1.91
2024-02-12
4
A
0
75000
0
A
2034-02-12
Common Stock
75000
75000
D
One third of the option becomes exercisable on February 12, 2025 and the remaining shares underlying the option become exercisable in equal increments on each of the 24 one-month anniversaries thereafter.
/s/ Michael Rowe
2024-02-14